How Education Can Help Clinicians Practicing on the Edge of Evolving Standards
Over the past five years, the national five-year survival rate for individuals living with lung cancer has increased from 26% to 28.4%.1 This improvement is largely attributed to new data on early detection, targeted therapies and immunotherapies.
As oncology moves toward precision-driven, biomarker-informed pathways, the bar for timely, tailored decision-making is rising, and this shift creates ambiguity in the treatment room. Therapeutic developments are often years ahead of guideline updates, leaving today’s clinicians to navigate a widening gap between emerging possibilities and existing protocols, without real-time support.
“New therapies lead to new toxicity profiles that must be shared with practicing physicians, nurse practitioners, and nurses to assure that patients are ideally managed while on therapy.”
— Aaron E. Lisberg, MD
Thoracic Medical Oncology, UCLAHealth
At Medlive, we respond to evidence shifts by designing digital education that helps clinicians apply emerging data where it matters most – at point-of-care. Our adaptive learning pathways, scenario-based modules and peer feedback– loops don’t just teach the ‘what’ – they address the ‘now what’, supporting individualized care for patients living with lung cancer.
“Together with Dr. Lisberg, we’ve been tackling areas of concern years in advance of broad use in clinical practice. In this respect, we do not wait for a practice gap to widen—we proactively surface friction points in care.”
— Tariqa Ackbarali, PhD, MS, CHCP
Vice President, Medical Oncology, Medlive
Today, education must do more than inform—it must anticipate. It needs to be as nimble as the science it supports and deeply embedded in clinician workflows.
If you’re heading to ASCO, come to booth #34070 to see how we’re building education that moves as fast as the science—or check out our latest real-world case discussions, emerging data updates, and peer insights at www.medlive.com/cancer anytime.
